FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4214903447> ?p ?o ?g. }

• W4214903447 endingPage "e054337" @default.
• W4214903447 startingPage "e054337" @default.
• W4214903447 abstract "Fear of cancer recurrence (FCR) is commonly reported by patients diagnosed with early-stage (0-II) melanoma and can have a significant impact on daily functioning. This study will pilot the implementation of the Melanoma Care Program, an evidence-based, psychological intervention to reduce FCR, into routine practice, using a stepped-care model.Intervention effectiveness and level of implementation will be investigated using a hybrid type I design. Between 4 weeks before and 1 week after their next dermatological appointment, patients with melanoma will be invited to complete the Fear of Cancer Recurrence Inventory Short-Form, measuring self-reported FCR severity. Using a stepped-care model, clinical cut-off points will guide the level of support offered to patients. This includes: (1) usual care, (2) Melanoma: Questions and Answers psychoeducational booklet, and (3) three or five psychotherapeutic telehealth sessions. This longitudinal, mixed-methods pilot implementation study aims to recruit 108 patients previously diagnosed with stage 0-II melanoma. The primary effectiveness outcome is change in FCR severity over time. Secondary effectiveness outcomes include change in anxiety, depression, stress, health-related quality of life and melanoma-related knowledge over time. All outcomes are measured at baseline, within 1 week of the final telehealth session, and 6 and 12 months post-intervention. Implementation stakeholders at each study site and interested patients will provide feedback on intervention acceptability and appropriateness. Implementation stakeholders will also provide feedback on intervention cost, feasibility, fidelity and sustainability. These outcomes will be measured throughout implementation, using questionnaires and semistructured interviews/expert group discussions. Descriptive statistics, linear mixed-effects regression and thematic analysis will be used to analyse study data.Ethics approval was granted by the Sydney Local Health District-Royal Prince Alfred Zone (2020/ETH02518), protocol number: X20-0495. Results will be disseminated through peer-reviewed journals, conference presentations, social media and result summaries distributed to interested participants. TRIAL REGISTRATION DETAILS: (ACTRN12621000145808)." @default.
• W4214903447 created "2022-03-05" @default.
• W4214903447 creator A5001301120 @default.
• W4214903447 creator A5005319580 @default.
• W4214903447 creator A5013626708 @default.
• W4214903447 creator A5016326471 @default.
• W4214903447 creator A5032281895 @default.
• W4214903447 creator A5032896073 @default.
• W4214903447 creator A5034174620 @default.
• W4214903447 creator A5040969461 @default.
• W4214903447 creator A5043969975 @default.
• W4214903447 creator A5055763548 @default.
• W4214903447 creator A5061349309 @default.
• W4214903447 creator A5080502743 @default.
• W4214903447 creator A5081462567 @default.
• W4214903447 date "2022-03-01" @default.
• W4214903447 modified "2023-10-18" @default.
• W4214903447 title "Protocol for the implementation of a stepped-care model to address fear of cancer recurrence in patients previously diagnosed with early-stage (0–II) melanoma" @default.
• W4214903447 cites W1765901980 @default.
• W4214903447 cites W1835103671 @default.
• W4214903447 cites W1953800697 @default.
• W4214903447 cites W1979290264 @default.
• W4214903447 cites W1991276220 @default.
• W4214903447 cites W2013886100 @default.
• W4214903447 cites W2021808126 @default.
• W4214903447 cites W2023999328 @default.
• W4214903447 cites W2029173731 @default.
• W4214903447 cites W2035968942 @default.
• W4214903447 cites W2043575619 @default.
• W4214903447 cites W2068018553 @default.
• W4214903447 cites W2083164476 @default.
• W4214903447 cites W2088994872 @default.
• W4214903447 cites W2125885438 @default.
• W4214903447 cites W2134431449 @default.
• W4214903447 cites W2137763204 @default.
• W4214903447 cites W2138397833 @default.
• W4214903447 cites W2182315688 @default.
• W4214903447 cites W2334201740 @default.
• W4214903447 cites W2385806894 @default.
• W4214903447 cites W2478739027 @default.
• W4214903447 cites W2531206681 @default.
• W4214903447 cites W2548380318 @default.
• W4214903447 cites W2567856510 @default.
• W4214903447 cites W2582406074 @default.
• W4214903447 cites W2587416630 @default.
• W4214903447 cites W2592673947 @default.
• W4214903447 cites W2604186184 @default.
• W4214903447 cites W2604629196 @default.
• W4214903447 cites W2742135261 @default.
• W4214903447 cites W2746295118 @default.
• W4214903447 cites W2750615195 @default.
• W4214903447 cites W2765868282 @default.
• W4214903447 cites W2768736194 @default.
• W4214903447 cites W2803191377 @default.
• W4214903447 cites W2918510652 @default.
• W4214903447 cites W2940101029 @default.
• W4214903447 cites W2952061954 @default.
• W4214903447 cites W2974137581 @default.
• W4214903447 cites W2983138989 @default.
• W4214903447 cites W3086563989 @default.
• W4214903447 cites W3128646645 @default.
• W4214903447 cites W3129258785 @default.
• W4214903447 cites W3172036793 @default.
• W4214903447 doi "https://doi.org/10.1136/bmjopen-2021-054337" @default.
• W4214903447 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35241467" @default.
• W4214903447 hasPublicationYear "2022" @default.
• W4214903447 type Work @default.
• W4214903447 citedByCount "2" @default.
• W4214903447 countsByYear W42149034472023 @default.
• W4214903447 crossrefType "journal-article" @default.
• W4214903447 hasAuthorship W4214903447A5001301120 @default.
• W4214903447 hasAuthorship W4214903447A5005319580 @default.
• W4214903447 hasAuthorship W4214903447A5013626708 @default.
• W4214903447 hasAuthorship W4214903447A5016326471 @default.
• W4214903447 hasAuthorship W4214903447A5032281895 @default.
• W4214903447 hasAuthorship W4214903447A5032896073 @default.
• W4214903447 hasAuthorship W4214903447A5034174620 @default.
• W4214903447 hasAuthorship W4214903447A5040969461 @default.
• W4214903447 hasAuthorship W4214903447A5043969975 @default.
• W4214903447 hasAuthorship W4214903447A5055763548 @default.
• W4214903447 hasAuthorship W4214903447A5061349309 @default.
• W4214903447 hasAuthorship W4214903447A5080502743 @default.
• W4214903447 hasAuthorship W4214903447A5081462567 @default.
• W4214903447 hasBestOaLocation W42149034471 @default.
• W4214903447 hasConcept C118552586 @default.
• W4214903447 hasConcept C139719470 @default.
• W4214903447 hasConcept C142724271 @default.
• W4214903447 hasConcept C159110408 @default.
• W4214903447 hasConcept C160735492 @default.
• W4214903447 hasConcept C162324750 @default.
• W4214903447 hasConcept C1862650 @default.
• W4214903447 hasConcept C204787440 @default.
• W4214903447 hasConcept C2776867660 @default.
• W4214903447 hasConcept C2779891985 @default.
• W4214903447 hasConcept C2779951463 @default.
• W4214903447 hasConcept C2780385302 @default.
• W4214903447 hasConcept C2780665704 @default.
• W4214903447 hasConcept C2781050511 @default.

• next